Venture Capital, Funding, Startup, Biotechnology, Biology.
benchtop and help make cell editing more widely available to patients in need. Our take: Leveraging recent advancements in technology to improve access to established science has been a core focus of ours at LH. We believe that most companies who tout their AI credentials will not stand the test of